Stock NEOD NEOS AB
Add to a list
To use this feature you must be a member
Log inSign up

Financials NEOS AB

Equities

NEOD

SE0021615655

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Stockholm
Other stock markets
 12:00:00 2024-06-26 pm EDT 		5-day change 1st Jan Change
0.882 SEK -4.96% Intraday chart for NEOS AB +8.35% -59.91%
Jun. 18 Norse Atlantic to Operate Boeing 787 Routes for Neos in Winter MT
Jun. 18 Norse Atlantic Airways Signs Agreement with Neos CI

Valuation

Fiscal Period: December 2020 2021 2022 2023 2024 2025
Capitalization 1 225.9 106 56.64 15.94 28.76 -
Enterprise Value (EV) 1 225.9 106 76.7 13.64 24.86 28.76
P/E ratio - -1.57 x - - - -
Yield - - - - - -
Capitalization / Revenue - - 420 x 21.2 x 0.9 x 0.32 x
EV / Revenue - - 568 x 18.2 x 0.78 x 0.32 x
EV / EBITDA - - -1.39 x -0.19 x -0.4 x -
EV / FCF - - -1,159,436 x - - -
FCF Yield - - -0% - - -
Price to Book - - - - - -
Nbr of stocks (in thousands) 603 603 1,205 7,246 32,611 -
Reference price 2 375.0 176.0 47.00 2.200 0.8820 0.8820
Announcement Date 2/17/21 2/16/22 2/17/23 2/16/24 - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025
Net sales 1 - - 0.135 0.751 32 89.2
EBITDA 1 - - -55.09 -72.66 -62.3 -
EBIT 1 - - -73.23 -90.96 -78.6 -39.8
Operating Margin - - -54,245.19% -12,111.19% -245.62% -44.62%
Earnings before Tax (EBT) - - - - - -
Net income -31.01 -67.73 - - - -
Net margin - - - - - -
EPS - -112.0 - - - -
Free Cash Flow - - -66.16 - - -
FCF margin - - -49,003.7% - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 2/17/21 2/16/22 2/17/23 2/16/24 - -
1SEK in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2023 Q1 2023 Q2 2023 Q3 2023 Q4
Net sales 1 0.097 0.02 - 0.204
EBITDA -18.56 - - -
EBIT 1 -23.16 -26.19 -22.12 -19.49
Operating Margin -23,871.13% -130,965% - -9,553.43%
Earnings before Tax (EBT) - - - -
Net income - - - -
Net margin - - - -
EPS - - - -
Dividend per Share - - - -
Announcement Date 5/11/23 7/31/23 11/28/23 2/16/24
1SEK in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025
Net Debt 1 - - 20.1 - - -
Net Cash position 1 - - - 2.3 3.9 -
Leverage (Debt/EBITDA) - - -0.3643 x - - -
Free Cash Flow - - -66.2 - - -
ROE (net income / shareholders' equity) - - - - - -
ROA (Net income/ Total Assets) - - - - - -
Assets - - - - - -
Book Value Per Share - - - - - -
Cash Flow per Share - - - - - -
Capex - - 0.76 - - -
Capex / Sales - - 562.96% - - -
Announcement Date 2/17/21 2/16/22 2/17/23 2/16/24 - -
1SEK in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for NEOS AB

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Quarterly revenue - Rate of surprise

Company calendar

Sector Medical Diagnostic & Testing Equipment

1st Jan change Capi.
NEOS AB Stock NEOS AB
-59.91% 2.72M
QUIDELORTHO CORPORATION Stock QuidelOrtho Corporation
-54.19% 2.26B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD. Stock Inner Mongolia Furui Medical Science Co., Ltd.
+19.59% 1.89B
SHANGHAI MICROPORT EP MEDTECH CO., LTD. Stock Shanghai MicroPort EP MedTech Co., Ltd.
-8.65% 1.52B
BIOTAGE AB Stock Biotage AB
+17.35% 1.19B
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD. Stock Shanghai AoHua Photoelectricity Endoscope Co., Ltd.
-24.23% 871M
REVENIO GROUP OYJ Stock Revenio Group Oyj
+1.25% 781M
CONTEC MEDICAL SYSTEMS CO.,LTD Stock Contec Medical Systems Co.,Ltd
-34.22% 750M
VAREX IMAGING CORPORATION Stock Varex Imaging Corporation
-29.46% 591M
CELLAVISION AB Stock CellaVision AB
+16.98% 560M
Medical Diagnostic & Testing Equipment
  1. Stock Market
  2. Equities
  3. NEOD Stock
  4. Financials NEOS AB